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Abstract
Background: The Carolinas Center for Medical Excellence launched the PEACE project in 2006, under
contract with the Centers for Medicare & Medicaid Services (CMS), to identify, develop, and pilot test quality
measures for hospice and palliative care programs.
Objectives: The project collected pilot data to test the usability and feasibility of potential quality measures and
data collection processes for hospice and palliative care programs.
Settings/subjects: Twenty-two hospices participating in a national Quality Improvement Collaborative (QIC)
submitted data from 367 chart reviews for pain care and 45 chart reviews for nausea care. Fourteen additional
hospices completed a one-time data submission of 126 chart reviews on 60 potential patient-level quality mea-
sures across eight domains of care and an organizational assessment evaluating structure and processes of care.
Design: Usability was assessed by examining the range, variability and size of the populations targeted by each
quality measure. Feasibility was assessed during the second pilot study by surveying data abstractors about the
abstraction process and examining the rates of missing data. The impact of data collection processes was
assessed by comparing results obtained using different processes.
Results: Measures shown to be both usable and feasible included: screening for physical symptoms on ad-
mission and documentation of treatment preferences. Methods of data collection and measure construction
appear to influence observed rates of quality of care.
Conclusions: We successfully identified quality measures with potential for use in hospices and palliative care
programs. Future research is needed to understand whether these measures are sensitive to quality improvement
interventions.
Introduction
In recognition of the growing proportion of Americansliving longer and dying from chronic diseases, the Institute
of Medicine (IOM) identified improving care for frail adults
and persons nearing end of life as a national priority area for
quality improvement.1 The need for improved data and
measurement systems for hospice and palliative care pro-
grams was subsequently highlighted.2 Measurement of care
for seriously ill and dying patients faces numerous method-
ological challenges, including, for example, a dearth of well-
validated measures, the fact that many patients at the end of
life are too sick to provide self-report assessments of quality,
and concerns about the accuracy of proxy reports.2
The National Consensus Project for Quality Palliative Care
(NCP) issued Consensus Clinical Practice Guidelines, now in
the third edition.3 The guidelines describe high-quality pal-
liative care practices in eight broad domains: structure and
processes; physical symptoms; psychological symptoms;
social concerns; spiritual and existential aspects; cultural
competency; care of the imminently dying patient; and,
ethical and legal aspects of care. These guidelines were en-
dorsed by the National Quality Forum (NQF), along with 38
preferred practices for hospice and palliative care programs.4
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The guidelines and preferred practices provide guidance to
providers on what constitutes good quality care. However,
they stop short of recommending specific quality measures. A
quality measure is based on an accepted standard of care and
uses detailed eligibility specifications and item definitions to
generate numerators and denominators.5
In 2008, Centers for Medicare and Medicaid Services
(CMS) published revised Conditions of Participation (COPs)
for hospices mandating all Medicare-certified hospices im-
plement systematic quality assessment and improvement.6
Recognizing the need for quality measurement tools for
hospice care, CMS asked The Carolinas Center for Medical
Excellence (CCME) to identify, develop, and pilot test a set
of quality measures and a procedure to assess and monitor the
quality of care. The PEACE project recommended 34 quality
measures and a data collection tool to assist hospice and
palliative care programs in monitoring their care.7 This ar-
ticle describes the pilot data processes and results used in the
selection of the PEACE measures.
Methods
The PEACE project team first identified 174 potential
quality measures consistent with the NCP domains of quality
from numerous sources.8 Measures deemed to have the
greatest potential for use in quality improvement in hospice
and palliative care programs were selected for further test-
ing. Investigators completed two data collection pilots. The
first pilot was undertaken in response to an invitation from
the National Hospice and Palliative Care Organization
(NHPCO). Member hospices participating in a Quality Im-
provement Collaborative (QIC) were eager to participate in
the testing of quality measures addressing care for physical
symptoms. The second pilot, designed by the study team,
relied on volunteer hospices that tested the data collection
processes but were not involved in organized efforts to ad-
dress the quality measures. These pilots were used to assess
the usability and feasibility of potential quality measures, and
data collection approaches.
The first pilot: Physical symptom
measures in a QIC
During a 7-month period in 2007, hospices participating in
a QIC submitted data monthly on 10 newly admitted patients
to NHPCO staff, who shared deidentified, individual level
data with the PEACE project team. Hospices addressing pain
collected data on four measures: screening for pain on ad-
mission, targeted assessment of pain, treatment of pain within
24 hours, and improvement within 24 hours. Hospices ad-
dressing nausea collected data on four similar measures for
nausea: screening, assessment, improvement and treatment
within 24 hours. All hospices collected data on the percent of
patients with weekly screening for physical symptoms. These
measures represent a subset of the PEACE measures.
The second pilot: Measures from multiple domains
with fourteen volunteer hospices
In summer 2007, 14 hospices from 7 states, representing
both freestanding and hospital-based providers responded to
an invitation to participate in a data collection pilot to test
quality measures from multiple domains. Each hospice
contributed data from 9 patient records, with 9 hospices
submitting data on their most recent 9 discharges and 5
hospices submitting data on their most recent 9 admissions.
Hospices collected data for denominator and numerator
elements separately using a structured data collection tool
with operational definitions for each data element. Abstrac-
tors did not know how the data would be used in quality
measures or whether a quality measure was or was not met.
Hospices were instructed not to institute new clinical docu-
mentation procedures for the pilot. If a data item could not be
found, they were told to mark the item as ‘‘unable to deter-
mine.’’
For quality measures calculated from both admission and
discharge records, we examined rates separately for admis-
sion charts and discharge charts. Few differences were noted,
so the data from both admission and discharge charts were
pooled to calculate aggregate rates.
Hospices in this pilot also completed an organizational
assessment of policies, standard processes of care, and care
coordination. Additionally, the chart abstractor from each
hospice in was asked to complete a Web-based survey about
the ease with which they could find specific types of data
(extremely easy or easy, and difficult or extremely difficult)
and how useful selected quality measures would be to their
hospice in trying to improve quality of care (very useful or
useful, and somewhat or not useful at all).
Assessment of measure usability and feasibility
Criteria to assess quality measures include usability and
feasibility.9 A usable measure provides results that can be
understood and used to improve quality. A feasible measure
includes data that can be retrieved without undue burden. We
assessed usability of quality measures by examining the
proportion of patients eligible for each quality measure, the
mean and range of values obtained, and chart abstractors’
assessment of the usefulness of each quality measure. We
assessed feasibility by examining the time it took to perform
the chart abstractions (in the second pilot), the quantity of
missing data for each measure, and abstractors’ assessment of
the difficulty of finding data needed for the measures. We
assessed the impact of different data collection methods by
comparing results obtained for measures that were used in
both pilots.
Results
In the first data pilot, 21 hospices worked on pain, pro-
viding 38 data submissions representing 367 chart reviews.
Two hospices worked on nausea, providing 5 data submis-
sions reporting on 45 chart reviews (Table 1).
In the second pilot, 14 hospices submitted data for 126
patients on 14 physical symptom measures (Table 2) and 9
measures in other domains (Table 3). All 14 hospices com-
pleted the organizational assessment. Thirteen hospices par-
ticipated in the Web-based survey on ease of gathering the
quality measure data and usability of the quality measures.
Usability: Percent of patients eligible
All patients in the first pilot were eligible for screening for
the symptoms of pain and nausea (Table 1). Quality measures
addressing targeted assessment and treatment were limited to
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Percent of patients who were screened for pain on admission 367 94% 70%–100%
Percent of patients who have pain identified on initial screening with a
targeted comprehensive assessment within 24 hours of admission
200 94% 33%–100%
Percent of patients who have pain identified on initial screening who receive
treatment within 24 hours of admission
199 95% 60%–100%
Percent of patients with pain on admission who report their pain was
improved within 24 hours of admission
199 68% 50%–100%
Percent of patients screened for nausea on admission 45 98% 92%–100%
Percent of patients with nausea on admission who have a targeted
comprehensive assessment within 24 hours of admission
12 100% 100%
Percent of patients with nausea who report their nausea was improved within
24 hours of admission
12 75% 40%–100%
Percent of patients who have nausea identified on initial screening who
receive treatment within 24 hours of screening
12 92% 80%–100%
Percent of patients for whom physical symptom screening is repeated weekly 392 91% 0%–100%
aThe first pilot included 22 hospices participating in a quality improvement collaborative.








Percent of patients who were screened for pain on admission 126 (100%) 6 (5%) 78% 22%–100%
Percent of patients who have pain identified on initial
screening who have a targeted comprehensive assessment
within 24 hours of admission
52 (41%) 14 (27%) 62% 0%–100%
Percent of patients who have pain identified on initial
screening who receive treatment within 24 hours of
admission
52 (41%) 16 (31%) 60% 33%–100%
Percent of patients with pain on admission who had an order
for regularly scheduled (not as-needed) pain medication
in 24 hours
52 (41%) 11 (21%) 48% 0%–100%
Percent of patients with pain on admission who report their
pain was improved within 24 hours of admission
52 (41%) 17 (33%) 15% 0%–100%
Percent of patients whose pain was at comfortable level
within 48 hours of admission (among patients in moderate
or severe pain)
29 (22%) 19 (66%) 17% 0%–100%
Percent of patient with cognitive and language problems
receiving targeted pain assessment
68 (54%) 32 (47%) 44% 0%–100%
Percent of patients who were screened for shortness of
breath on admission
126 (100%) 4 (3%) 78% 22%–100%
Percent of patients who have shortness of breath identified
on initial screening who receive treatment within 24 hours
of admission
40 (40%) 19 (47%) 47% 0%–100%
Percent of patients who have shortness of breath who report
their shortness of breath was improved within 24 hours of
admission
40 (40%) 22 (55%) 7.50% 0%–33%
Percent of patients who have nausea identified on initial
screening who receive treatment within 24 hours of
screening
14 (11%) 7 (50%) 50% 0%–100%
Percent of patients who have constipation identified on
initial screening who receive treatment within 24 hours of
admission
19 (15%) 6 (32%) 53% 0%–100%
Percent of patients with bowel regimen initiated within 24
hours of an opioid among those treated with narcotics
29 (23%) 11 (38%) 52% 0%–100%




17 (21%) 30% 0%–57%
aThe second pilot included 14 hospices who volunteered to participate in a data collection pilot.
bPercent missing or unable to determine (UTD) is calculated as follows: the numerator includes all patients for whom one or more
elements needed to calculate the quality measure were not found in the chart or the response option unable to determine was checked; the
denominator includes all patients who were affected by the symptom.
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patients who were found to have the targeted physical
symptom on admission: 54% of patients had pain and 27%
had nausea.
In the second pilot, six measures were applicable to all
patients: screening on admission for pain and shortness
of breath; assessment of spiritual concerns; documenta-
tion of preferences for treatments; advanced directive or
documentation of discussion; and documentation of surrogate
decision-maker (Tables 2 and 3). Two additional measures
were applicable to all discharge records: comprehensive as-
sessment within 5 days of admission and moderate or severe
pain the last week of life. The remaining measures applied
only to patients with specific symptoms or conditions.
Of the measures not universally applicable, the measure
targeting patients with communication problems represented
the largest proportion of patients, 54%, followed by the
measure targeting patients with cognitive programs, which
applied to 45%. Measures for assessment and treatment of
pain and dyspnea applied to nearly half of patients. However,
since few patients had nausea (11%), depression (10%) and
anxiety (17%), quality measures for treatment of these
symptoms applied to only a small proportion of the study
group.
Usability: Mean and range of values
Mean scores of the quality measures from the first pilot
were, on the whole, fairly high, reaching 90% or higher for
seven of the nine measures (Table 1). Only two measures had
aggregate rates less than 90%: improvement in pain (68%)
and improvement in nausea (75%). However, individual
hospice scores varied widely for most measures, except for
targeted assessment among those with nausea, for which all
hospices reported 100%.
In contrast, most measures in the second data pilot indi-
cated substantial room for improvement (Tables 2 and 3).
Only three measures had aggregate rates above 80%: as-
sessment of spiritual concerns; treatment for patients with
anxiety and documentation of preferences for life-sustaining
treatments. The observed rates for the remaining measures
varied from a low of 7.5% for the percent of patients who had
dyspnea improved within 24 hours of admission to a high of
78% for screening for pain and dyspnea.
Usability: Rating by abstractors in the second pilot
Eight types of measures, representing 19 tested quality
measures, were assessed as useful or very useful by 75% or
more of abstractors (Table 4). Measures rated as being most
useful included those that assessed screening, treatment and
improvement of physical symptoms, treatment for psycho-
logical concerns, assessment of spiritual concerns, docu-
mentation of preferences for treatment, advance directives,
and documentation of surrogate decision makers.
Feasibility
Information about the time required for chart abstraction
was collected from hospices in the second pilot that exam-
ined discharge records (n = 80). The data collection gener-
ating information on 60 quality measures took less than
1 hour for 40% of the charts, 1–2 hours for 44% of the
charts, and over 2 hours for 6% (abstraction time was not
reported in 8 charts).





or UTDb n (%)
Aggregate
rate Range
Percent of patients for whom the comprehensive assess-
ment is completed in £ 5 days of admissionc
80 (100% of
discharged patients)
48 (60%) 25% 0%–78%
Percent of residents who screen positively for depression
for whom follow-up was initiated
12 (10%) 1 (8%) 17% 0%–50%
Percent of patient with diagnosis of depression who
receive treatment within 2 weeks
12 (10%) 3 (25%) 43% 0%–100%
Percent of patients with anxiety who received treatment 22 (17%) 1 (5%) 82% 0%–100%
Percent of patients who have documented discussion of
to identify spiritual or religious concerns as they affect
care
126 (100%) 3 (2%) 91% 57%–100%
Percent of patients with written documentation of their
preference for life-sustaining treatments prominently
display in chart
126 (100%) 4 (3%) 82% 0%–100%
Percent of patients who have advanced directive or
documentation of discussion
126 (100%) 32 (25%) 44% 12%–90%
Percent of patients who have documentation of surrogate
decision-maker
126 (100%) 29 (23%) 57% 0%–100%
Percent of patient with dementia, coma, or other altered
mental status who have documentation of surrogate
decision-maker in chart in 48 hours
57 (45%) 28 (49%) 37% 0%–75%
aThe second pilot included 14 hospices that volunteered to participate in a data collection pilot.
bPercent missing or unable to determine (UTD) is calculated as follows: the numerator includes all patients for whom one or more
elements needed to calculate the quality measure were not found in the chart or the response option unable to determine was checked; the
denominator includes all patients affected by the symptom or all patients who could benefit from the care being measured.
cComprehensive assessment included assessment of the following: prognosis, functional status, physical symptoms, psychological
symptoms, spiritual needs, and social needs.
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In the second data pilot, the extent of missing data varied
greatly. The six measures with the least missing data (missing
for less than 10% of patients) were: screening for pain and
dyspnea on admission, discussion of spiritual concerns,
treatment of depression and anxiety, and treatment prefer-
ence documentation. Four measures had missing data levels
of 50% or higher: achieving comfort for those in pain within
48 hours; improvement of shortness of breath in 24 hours;
treatment of nausea within 24 hours; and completion of a
comprehensive assessment within 5 days of admission.
Four types of measure data were universally noted by
abstractors as easy to find: screening for physical symptoms
(e.g., pain, nausea, dyspnea); comprehensive assessment
for those with physical symptoms; reassessment of physi-
cal symptoms; and documentation of spiritual concerns.
Abstractors reported difficulty finding included assessment
of and improvement of psychological symptoms, and as-
sessments of spiritual, family, social, or grief concerns.
Impact of different data collection processes
Four measures were collected in both pilots: screening for
pain on admission, assessment and treatment for pain within
24 hours; and treatment of nausea within 24 hours. For each
of these measures, the rates in the first pilot were over 90%,
although there were variations at the hospice level (Table 1).
During the second pilot, no rates above 90% were observed.
The highest observed rate was 78% for screening for pain;
rates for the other three measures were considerably lower.
We compared results from chart data and organizational
data documentation of advanced directives and two data
items used to construct measures: the use of numeric scores
for pain and dyspnea. In the organizational data, 93% of
hospices reported advanced directive information was always
documented. However, in the chart abstraction, it was miss-
ing 25% of the time. Similarly, 100% of hospices reported
using numeric scores to assess pain and 85% reported using
Table 4. Assessment of Usefulness of Quality Data from Chart Abstractors in the Second Pilota
Description of data rated by
charted abstractor Related measure
Useful or very
useful (percent)
Screening for physical symptoms
within a timeframe from
admission
Percent of patients who were screened for pain on admission 77%
Percent of patients who were screened for shortness of breath on
admission
Percent of patients screened for nausea on admission
Receiving treatment for physical
symptoms within a timeframe
Percent of patients who have pain identified on initial screening
who receive treatment within 24 hours of admission
77%
Percent of patients with pain on admission who had an order for
regularly scheduled (not as-needed) pain medication in 24 hours
Percent of patients who have shortness of breath identified on
initial screening who receive treatment within 24 hours of
admission
Percent of patients who have nausea identified on initial screening
who receive treatment within 24 hours of screening
Percent of patients who have constipation identified on initial
screening that receive treatment within 24 hours of admission
Percent of patients with bowel regimen initiated within 24 hours
of an opiate among those treated with narcotics
Improvement in physical
symptoms
Percent of patients with pain on admission who report their pain
was improved within 24 hours of admission
85%
Percent of patients whose pain was at comfortable level within 48
hours of admission (among patients in moderate or severe pain)
Percent of patients who have shortness of breath who report their
shortness of breath was improved within 24 hours of admission
Treatment of psychological
symptoms
Percent of residents who screen positively for depression for
whom follow-up was initiated
85%
Percent of patients with diagnosis of depression who receive
treatment within 2 weeks
Percent of patients with anxiety who received treatment
Discussion of spiritual concerns Percent of patients who have documented discussion of to identify
spiritual or religious concerns as they affect care
85%
Documentation of end of life
treatment preferences
Percent of patients with written documentation of their preference








decision maker for those with
cognitive problems
Percent of patients with dementia, coma, or other altered mental
status who have documentation of surrogate decision maker in
chart in 48 hours
77%
aThe second pilot included 14 hospices that volunteered to participate in a data collection pilot. Thirteen abstractors from these hospices
responded to the survey on the data collection process.
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numeric scores for dyspnea. Yet, we found numeric scores in
69% of patient records for pain assessment and in 0% of the
records of patients with dyspnea.
Discussion
We identified five measures as both usable and feasible:
screening for pain, screening for dyspnea, screening for
nausea, documentation of spiritual concerns, and documen-
tation of preferences for end-of-life treatments. These mea-
sures are applicable to all patients, demonstrate room for
improvement, were assessed by hospice staff as useful, and
are based on data elements hospice staff assessed as easy to
locate. Four of these measures also had very little missing
data (screening for pain and dyspnea, documentation of
spiritual concerns, and end-of-life preferences). We could not
assess missing data for the nausea screening measure, but its
similarity to the other screening measures suggests that it
would likely be associated with very little missing data. Two
additional ‘‘all patient’’ measures were assessed as useful by
hospice staff and created with data elements deemed easy to
locate: advanced directives and documentation of a surrogate
decision maker. However, these two measures had relatively
high missing data rates (25% and 23%, respectively), sug-
gesting they were less feasible.
Of the symptom specific measures, those addressing care
for pain (41%) and dyspnea (32%) affected the largest portion
of the population. One of these measures, the percent of pa-
tients with moderate or severe pain on admission who are
comfortable within 48 hours has been designated by CMS as
a measure for which hospices will be required to report data
beginning in 2014.10 However, this measure, when collected
through chart review, had high rates of missing data. Other
important symptoms—nausea, constipation, depression, and
anxiety—were less prevalent in the patient population. For
measures that address less prevalent symptoms, missing data
can be more problematic, further reducing an already a small
denominator Quality measures based on small numbers of
patients, whether due to prevalence of the symptom or
missing data, will be statistically unstable, making them less
useful for quality improvement.
Our results suggest that data collection method matters.
For the four measures common to both pilots, quality mea-
sure rates in the first pilot were considerably higher. The
approach in the first pilot, which involved recording mea-
sures as met or unmet, is a commonly used approach in
quality improvement initiatives. The approach in the second
pilot involved recording the numerator and denominator el-
ements separately with subsequent calculation of quality
measures. Although it is possible that the quality of care was
simply higher in the first group of hospices, it is also possible
the approach in the first pilot overestimates performance.
Seven of the nine measures collected using this approach
exhibited a ceiling effect, with rates of 90% and higher. These
observations suggest caution is needed when comparing
quality measure data collected using different measurement
procedures. Additional work exploring the influences of the
data collection processes is needed to identify preferred data
collection methods.
Our results suggest organizational measures, such as the
presence of policies and procedures, cannot be seen as a
reflection of high-quality care at the individual level. A struc-
tural measure, the presence of a quality improvement program
in hospices, has been proposed by CMS as a measure for hos-
pice reporting in 2014.10
Our pilots also identified gaps in quality measures. Two
measures representing core aspects of hospice care, pain re-
lief and improvement of shortness of breath, were rated as
very useful by chart abstractors. However, these measures
had extremely high rates of missing data. In the organiza-
tional assessment, the most common response to the question
about how often screening was repeated was ‘‘as-needed.’’
The lack of specified rescreening intervals makes it unclear
what constitutes a ‘‘timely’’ care plan (Preferred Practice 6)6
and makes quality measurement in this domain difficult.
Measures for providing culturally sensitive care, promoted
by two of the NQF preferred practices (#24 and #25),4 were
not available. We asked hospices in the second pilot about
their collection of information on the ethnicity and primary
language of their patients, staff and surrounding communi-
ties. Only half the hospices indicated they collected this in-
formation for all three populations. Simply knowing this
information is not sufficient to assure culturally sensitive
care, but it is a necessary first step.
Similarly, we were unable to identify measures for asses-
sing the quality of spiritual care. Our measure on screening
for spiritual concerns indicated high rates of assessment of
concerns but reveals little about whether spiritual concerns
are addressed.
Our pilots relied on volunteer hospices that may have
different care practices and documentation from other hos-
pices. Additionally, both pilots occurred prior to the im-
plementation of the 2008 Conditions of Participation. It is
possible that documentation of care and the ability to capture
elements of care has improved.
Conclusions
Quality data serve many audiences and purposes.9 Provi-
ders can use quality measures to identify and improve care
processes. Consumer can use them to identify better per-
forming providers. Governmental agencies and payers can
use them for accountability. At the time of this project, there
was much speculation that public reporting of quality mea-
sures in hospice was imminent, and that a ‘‘Hospice Com-
pare’’ website might be on the horizon, similar to those CMS
created for hospitals, nursing homes and home health agen-
cies.11–13 While public reporting of quality provided by
hospices has not yet materialized, the Affordable Care Act
requires hospices to report quality data to CMS beginning in
2014.14
The PEACE data pilots have highlighted a few quality
measures with potential for use in hospices and palliative care
programs. These measures offer hospices the potential to
identify areas of care that can be improved. Hospices vary in
their capacity to collect and use quality data. Hanson and
colleagues15 found hospices that were smaller, in rural set-
tings, and those with for-profit tax status were less prepared to
implement quality improvement. Identifying a few usable
and feasible quality measures could be a step towards in-
creasing the ability of hospice providers to use quality mea-
sure to improve care.
Our study also identified measures that do not seem to
work and areas where additional work is needed. A number of
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measurement concerns were identified: measures that repre-
sent a few of patients, measures where data are frequently
missing, and measures that demonstrate a ceiling effect. Ad-
ditional testing of the measures and measurement processes is
needed in hospice and palliative care programs. A compre-
hensive system to measure quality care for seriously ill and
dying patients is an important goal. Scientifically sound and
usable quality measures are needed to achieve that goal.
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